Shattuck Labs STTK Stock
Shattuck Labs Price Chart
Shattuck Labs STTK Financial and Trading Overview
| Shattuck Labs stock price | 4.75 USD |
| Previous Close | 5.95 USD |
| Open | 5.94 USD |
| Bid | 4.27 USD x 200 |
| Ask | 7.28 USD x 200 |
| Day's Range | 5.64 - 5.98 USD |
| 52 Week Range | 0.71 - 8.33 USD |
| Volume | 713.83K USD |
| Avg. Volume | 609.11K USD |
| Market Cap | 433.24M USD |
| Beta (5Y Monthly) | 1.186 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.56 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.5 USD |
STTK Valuation Measures
| Enterprise Value | 368.72M USD |
| Trailing P/E | N/A |
| Forward P/E | -11.043137 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 433.24496 |
| Price/Book (mrq) | 4.3394775 |
| Enterprise Value/Revenue | 368.719 |
| Enterprise Value/EBITDA | -7.534 |
Trading Information
Shattuck Labs Stock Price History
| Beta (5Y Monthly) | 1.186 |
| 52-Week Change | 469.37% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 8.33 USD |
| 52 Week Low | 0.71 USD |
| 50-Day Moving Average | 6.7 USD |
| 200-Day Moving Average | 3.88 USD |
STTK Share Statistics
| Avg. Volume (3 month) | 609.11K USD |
| Avg. Daily Volume (10-Days) | 528.43K USD |
| Shares Outstanding | 76.68M |
| Float | 47.71M |
| Short Ratio | 2.54 |
| % Held by Insiders | 5.25% |
| % Held by Institutions | 73.21% |
| Shares Short | 1.32M |
| Short % of Float | 1.79% |
| Short % of Shares Outstanding | 1.71% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -5258.29% |
| Gross Margin | -297.80% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.66% |
| Return on Equity (ttm) | -61.036% |
Income Statement
| Revenue (ttm) | 1M USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -2978000 USD |
| EBITDA | -48940000 USD |
| Net Income Avi to Common (ttm) | -49874000 USD |
| Diluted EPS (ttm) | -0.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 90.42M USD |
| Total Cash Per Share (mrq) | 1.18 USD |
| Total Debt (mrq) | 2.89M USD |
| Total Debt/Equity (mrq) | 3.02 USD |
| Current Ratio (mrq) | 22.065 |
| Book Value Per Share (mrq) | 1.302 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -41274000 USD |
| Levered Free Cash Flow (ttm) | -22423376 USD |
Profile of Shattuck Labs
| Country | United States |
| State | TX |
| City | Austin |
| Address | 500 West 5th Street |
| ZIP | 78701 |
| Phone | 512 900 4690 |
| Website | https://www.shattucklabs.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 40 |
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Q&A For Shattuck Labs Stock
What is a current STTK stock price?
Shattuck Labs STTK stock price today per share is 4.75 USD.
How to purchase Shattuck Labs stock?
You can buy STTK shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shattuck Labs?
The stock symbol or ticker of Shattuck Labs is STTK.
Which industry does the Shattuck Labs company belong to?
The Shattuck Labs industry is Biotechnology.
How many shares does Shattuck Labs have in circulation?
The max supply of Shattuck Labs shares is 76.68M.
What is Shattuck Labs Price to Earnings Ratio (PE Ratio)?
Shattuck Labs PE Ratio is now.
What was Shattuck Labs earnings per share over the trailing 12 months (TTM)?
Shattuck Labs EPS is -0.56 USD over the trailing 12 months.
Which sector does the Shattuck Labs company belong to?
The Shattuck Labs sector is Healthcare.
Shattuck Labs STTK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Select Market Com NQGS | 13180.97 USD — |
-0.87
|
— — | 13139.79 USD — | 13316.81 USD — | — - | — — |
| US Tech Biotechnology NBI | 5807.22 USD — |
+1.87
|
— — | 5685.34 USD — | 5809.82 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}